AI assistant
Sending…
Encompass Health Corp — Director's Dealing 2021
Mar 4, 2021
30484_dirs_2021-03-04_1b713a47-9ada-475d-96a2-ef05c6e91f70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Encompass Health Corp (EHC)
CIK: 0000785161
Period of Report: 2021-03-02
Reporting Person: Anthony April Kaye Bullock (CEO & President, Home Health)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-02 | Non-qualified Stock Option (Right to Buy) | $80.40 | A | 9375 | Acquired | 2031-03-02 | Encompass Health Common Stock (9375) | Direct |
Footnotes
F1: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.
More from Encompass Health Corp
Capital/Financing Update
2026
Jun 1
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26